Caricamento...
Tandutinib inhibits the Akt/mTOR signaling pathway to inhibit colon cancer growth
The c-Kit receptor can activate distinct signaling pathways including phosphatidylinositol-3-kinase (PI3K)/Akt and mammalian target of rapamycin (mTOR). Aberrant c-Kit activation protects cells from apoptosis and enhances invasion of colon carcinoma cells. Tandutinib is a novel quinazoline-based inh...
Salvato in:
| Pubblicato in: | Mol Cancer Ther |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2013
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4418457/ https://ncbi.nlm.nih.gov/pubmed/23427297 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-12-0907 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|